Cytochrome p450 (2D6)

Active Research Protocols

  1. 11-C-0061 – Phase I Trial of Z-Endoxifen in Adults with Refractory Hormone Receptor-Positive Breast Cancer, Desmoid Tumors, Gynecologic Tumors, or other Hormone Receptor-Positive Solid Tumors
NOTE: PDF documents require the free
Adobe Reader.
This page was last updated: January 24, 2014